BCAX
Bicara TherapeuticsrBCAX
$9.31-2.29%24H
BCAX / USDNASDAQ
Use arrow keys to change the interval
NAV$156.35
Liquidity—
Holders1
Circulating Supply16.79
Chains
ProviderReality Finance
P/E Ratio—
Market Cap$671.17M
EPS-3.46
52 Week Range$7.87 – $30.99
Volume$2.47M
Other Issuers—
NameBicara Therapeutics
TickerrBCAX
DividendsNo
Asset ClassStocks
Redemption Fees0.00%
Subscription Fees0.00%
IssuerReality Finance
Custodian—
Crypto Custodian—
Inception—
DomicileEl Salvador
Resolution Country—
About Bicara Therapeutics Inc. Common Stock

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. The company is headquartered in Boston, Massachusetts.

HeadquartersBOSTON, MA

Buy

—
—
Trending
SPCXB
SpaceX
$144.271.83%
Details
FXIon
iShares China Large-Cap ETF
$32.571.00%
Details
NVDAB
NVIDIA
$152.172.11%
Details

Help